1. Home
  2. SRPT vs FLX Comparison

SRPT vs FLX Comparison

Compare SRPT & FLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • FLX
  • Stock Information
  • Founded
  • SRPT 1980
  • FLX 2013
  • Country
  • SRPT United States
  • FLX China
  • Employees
  • SRPT N/A
  • FLX N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • FLX
  • Sector
  • SRPT Health Care
  • FLX
  • Exchange
  • SRPT Nasdaq
  • FLX NYSE
  • Market Cap
  • SRPT N/A
  • FLX N/A
  • IPO Year
  • SRPT 1997
  • FLX 2024
  • Fundamental
  • Price
  • SRPT $36.27
  • FLX $2.28
  • Analyst Decision
  • SRPT Buy
  • FLX
  • Analyst Count
  • SRPT 23
  • FLX 0
  • Target Price
  • SRPT $131.09
  • FLX N/A
  • AVG Volume (30 Days)
  • SRPT 4.0M
  • FLX 17.0K
  • Earning Date
  • SRPT 05-06-2025
  • FLX 05-27-2025
  • Dividend Yield
  • SRPT N/A
  • FLX N/A
  • EPS Growth
  • SRPT N/A
  • FLX N/A
  • EPS
  • SRPT N/A
  • FLX N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • FLX $612,152,319.00
  • Revenue This Year
  • SRPT $64.51
  • FLX N/A
  • Revenue Next Year
  • SRPT $22.40
  • FLX N/A
  • P/E Ratio
  • SRPT N/A
  • FLX N/A
  • Revenue Growth
  • SRPT 59.15
  • FLX N/A
  • 52 Week Low
  • SRPT $35.46
  • FLX $2.01
  • 52 Week High
  • SRPT $173.25
  • FLX $21.95
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 22.68
  • FLX N/A
  • Support Level
  • SRPT $35.46
  • FLX N/A
  • Resistance Level
  • SRPT $64.80
  • FLX N/A
  • Average True Range (ATR)
  • SRPT 3.78
  • FLX 0.00
  • MACD
  • SRPT -1.64
  • FLX 0.00
  • Stochastic Oscillator
  • SRPT 2.76
  • FLX 0.00

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: